Document is current
Any future updates will be listed below
-
Authors
Hiller, John Kim
Sandås, Elise Mørk
Rootwelt, Helge
Vassli, Anja Østeby
Lumi, Xhevat
Moe, Morten Carstens
Utheim, Tor Paaske
Elgstøen, Katja Benedikte Prestø
Petrovski, Goran
-
Funding
Funding for this research was provided by:
University of Oslo
- License Information
-
More Information
Article History
Received: 27 March 2025
Accepted: 13 May 2025
First Online: 22 May 2025
Declarations
:
: Provided in the Patients and Methods section.
: Not applicable.
: M.C.M.: Bayer (consultant), Novartis (consultant), Roche (consultant), Apellis (consultant), and SJJ Solutions (consultant, patent share).G.P.: AbbVie (consultant), Bulbitech (consultant), Profundus (consultant), RetinaRISK (consultant), and Roche (consultant).
